Respuesto, Antonio B.
HRN: 23-54-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/17/2023
08/24/2023
IV
500mg
Every 8 Hours
Incarcerated Indirect Inguinal Hernia, Right
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes